Cenyx Biotech

Developer of nanozyme based therapeutics for subarachnoid hemorrhage

placeSeoul, Seoul, South Korea calendar_todayFounded 2017 groups33 employees language cenyxbiotech.com

Innovation

10 patent families (6 granted) — focus: Human necessities; filing pace steady. Cited 146 times.

YearFilings
20171
20182
20192
20213
20222
20235
20242
20254
20262

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital686%
Private equity114%
Coming soon